cflowking's profile picture. Scott@cflowking.com. You’re invited to play CASHFLOW. Call 310-428-3680 (http://www.wlasuccessclub.org)

Scott Kaiserman

@cflowking

[email protected]. You’re invited to play CASHFLOW. Call 310-428-3680 (http://www.wlasuccessclub.org)

Scott Kaiserman reposted

Out of all the "how to be happier hacks" this is the one you need to know ⬇️


Scott Kaiserman reposted

Two high school seniors from New Orleans are making major waves in the world of academia after solving a mathematical equation involving the Pythagorean Theorem that has stumped mathematicians for the last 2,000 years. theblackwallsttimes.com/2023/03/28/new…


Scott Kaiserman reposted

Didn’t expect that 😂 (via @BeachGalloway)


Scott Kaiserman reposted

Sat. And Sunday 12 to 5pm, Thank you for asking.

Fml just seeing this😩when will you be out again?



Scott Kaiserman reposted

Happy Sunday! Serving 2day noon till 5pm. 5609 sunset Blvd. And st. Andrew 's


Scott Kaiserman reposted

We’re thrilled to announce the launch of a new antibody research initiative aimed at a functional cure for #HIV, and prevention of malaria. Learn more: bit.ly/3nnRuwc

Vir_Biotech's tweet image. We’re thrilled to announce the launch of a new antibody research initiative aimed at a functional cure for #HIV, and prevention of malaria. Learn more: bit.ly/3nnRuwc

Scott Kaiserman reposted

Today Vir/@GSK announced we are seeking an Emergency Use Authorization amendment to add an intramuscular route of administration for our investigational #COVID19 monoclonal antibody for early treatment of high-risk patients, based on positive Phase 3 data. bit.ly/3qqGH6B

Vir_Biotech's tweet image. Today Vir/@GSK announced we are seeking an Emergency Use Authorization amendment to add an intramuscular route of administration for our investigational #COVID19 monoclonal antibody for early treatment of high-risk patients, based on positive Phase 3 data. bit.ly/3qqGH6B

Scott Kaiserman reposted

Pleased to announce the start of a new #HBV clinical trial evaluating a potential functional cure regimen that includes our investigational small interfering ribonucleic acid, @GileadSciences' investigational TLR-8 agonist and an approved PD-1 inhibitor. bit.ly/3IzEahn

Vir_Biotech's tweet image. Pleased to announce the start of a new #HBV clinical trial evaluating a potential functional cure regimen that includes our investigational small interfering ribonucleic acid, @GileadSciences' investigational TLR-8 agonist and an approved PD-1 inhibitor. bit.ly/3IzEahn

Scott Kaiserman reposted

Vir and @GSK are pleased to share the link to the preclinical data posted on @biorxivpreprint demonstrating the in vitro activity of our investigational #COVID19 monoclonal antibody against the full known #Omicron spike protein. Learn more here: bit.ly/3rLIVyf

Vir_Biotech's tweet image. Vir and @GSK are pleased to share the link to the preclinical data posted on @biorxivpreprint demonstrating the in vitro activity of our investigational #COVID19 monoclonal antibody against the full known #Omicron spike protein. Learn more here: bit.ly/3rLIVyf

Scott Kaiserman reposted

Vir and partner @GSK are pleased to announce the UK’s regulatory agency, @MHRAgovuk, granted a conditional marketing authorization to our investigational #COVID19 monoclonal antibody. Learn more: bit.ly/3pl0Edg

Vir_Biotech's tweet image. Vir and partner @GSK are pleased to announce the UK’s regulatory agency, @MHRAgovuk, granted a conditional marketing authorization to our investigational #COVID19 monoclonal antibody. Learn more: bit.ly/3pl0Edg

Scott Kaiserman reposted

Vir/@GSK shared pre-print data demonstrating our investigational #COVID19 monoclonal antibody retains activity against key mutations of the #Omicron variant. Further testing to confirm activity against the combination of all Omicron mutations is underway. bit.ly/3ofPp6q

Vir_Biotech's tweet image. Vir/@GSK shared pre-print data demonstrating our investigational #COVID19 monoclonal antibody retains activity against key mutations of the #Omicron variant. Further testing to confirm activity against the combination of all Omicron mutations is underway. bit.ly/3ofPp6q

Scott Kaiserman reposted

Vir and partner @GSK are pleased to announce the signing of a new US government purchase agreement for our investigational #COVID19 monoclonal antibody, which increases access nationwide. Learn more: bit.ly/3r0pamv

Vir_Biotech's tweet image. Vir and partner @GSK are pleased to announce the signing of a new US government purchase agreement for our investigational #COVID19 monoclonal antibody, which increases access nationwide. Learn more: bit.ly/3r0pamv

Scott Kaiserman reposted

Our US government contracts now total approximately $1 billion and bring the total number of doses sold through binding agreements to more than 750,000 globally.


Congratulations!

We are thrilled to share that Vir ranked #17 on @Inc's inaugural list of “America’s 250 Best-Led Companies.” Thank you, @Inc, for acknowledging the strong leadership of our company. bit.ly/3BJ3vAC

Vir_Biotech's tweet image. We are thrilled to share that Vir ranked #17 on @Inc's inaugural list of “America’s 250 Best-Led Companies.” 

Thank you, @Inc, for acknowledging the strong leadership of our company. bit.ly/3BJ3vAC


Feeling hopeful. We lost someone very close to us because of liver damage caused by Hepatitis B

We are pleased to share that multiple abstracts highlighting data from our hepatitis B (#HBV) clinical program, as well as health outcomes research, have been accepted for presentation at @AASLDtweets The Liver Meeting, taking place November 12-15. bit.ly/3lIfeuw #TLMdX

Vir_Biotech's tweet image. We are pleased to share that multiple abstracts highlighting data from our hepatitis B (#HBV) clinical program, as well as health outcomes research, have been accepted for presentation at @AASLDtweets The Liver Meeting, taking place November 12-15. bit.ly/3lIfeuw
#TLMdX


Scott Kaiserman reposted

#BREAKING Today, Vir announced the first marketing authorization for our first commercial product, with provisional approval of our monoclonal antibody for the early treatment of #COVID19 in Australia. Read more: bit.ly/3sGrwpb

Vir_Biotech's tweet image. #BREAKING Today, Vir announced the first marketing authorization for our first commercial product, with provisional approval of our monoclonal antibody for the early treatment of #COVID19 in Australia.

Read more: bit.ly/3sGrwpb

Scott Kaiserman reposted

Together with our partner @GSK, we’ve submitted a Special Approval for Emergency application to the government of Japan for our single-dose investigational monoclonal antibody for treatment of #COVID19. For more details: bit.ly/2YrP99V

Vir_Biotech's tweet image. Together with our partner @GSK, we’ve submitted a Special Approval for Emergency application to the government of Japan for our single-dose investigational monoclonal antibody for treatment of #COVID19.

For more details: bit.ly/2YrP99V

Scott Kaiserman reposted
aliveness_ape's tweet image.

Scott Kaiserman reposted

Congratulations to the people of America for keeping the dance of Democracy going. Celebration of people's power over all other considerations. Let's forever value the privilege of people electing their own masters. Victory for not any one group but for the spirit of freedom.- Sg


Scott Kaiserman reposted

Happy New Year, everybody! If you need me in 2018, here's where you can find me! ...


Loading...

Something went wrong.


Something went wrong.